Midsize and startup drug developers in the Philadelphia region saw their market capitalization drop by nearly $3.7 billion during the first half of 2022.
Read the full article at: www.bizjournals.com
Midsize and startup drug developers in the Philadelphia region saw their market capitalization drop by nearly $3.7 billion during the first half of 2022.
Read the full article at: www.bizjournals.com
Recruitment marketing and employer branding services tailored for…
Get the latest life science news delivered to your inbox weekly.
We use cookies to give you the best experience on our website. Choose which categories you want to allow.
Choose which categories you want to allow. Strictly necessary cookies are always active.